TransMedics · TMDX
2 decks published between 2024-01-14 and 2025-01-10 — 348 pages, 342 analysed slides total.
initial thesis
follow up
Timeline
-
2024-01-14 follow up
CPTMDX
6pp · regulatory_filingScorpion petitions the FDA to suspend TransMedics' OCS Liver approval, citing pervasive off-label use, necrotic-organ device failures, and an alleged systematic cover-up of safety issues from regulators.
-
2025-01-10 initial thesis
TMDX
342pp · research_noteTransMedics is a Medicare billing-fraud and kickback racket whose top transplant-center customers are fleeing as cheaper alternatives arrive — Scorpion sets a $0 target.